Theoretically, the level of CD8+ T infiltration into the TME correlates with the efficacy of immunotherapy, since blocking the PD-1/PD-L1 interaction can restore the tumor-killing effect of exhausted CD8+ T cells (137). Here, CD8A is linked to neoplasm.